Innovation-driven Commitment to Antibacterial Discovery
At the session on antimicrobial resistance held at the OneNucleus Genesis conference in December 2020, Evotec's VP Anti-infectives Antonio Felici and other field experts discussed how innovation is instrumental in successfully developing new antibacterials.
If the video has not loaded above, please click here.
